Skip to main content

Young Researchers Forum - Identify and Characterize the Cancer Stemness Role of Maelstrom in Hepatocellular Carcinoma

Abstract: 

Hepatocellular carcinoma (HCC) is the fourth most common type of cancer in Hong Kong SAR and ranks as the third leading mortality rate of cancer type worldwide. A wise strategy for better understanding the enrolled molecular mechanisms in HCC progression, which is needed to discover novel diagnostic markers and therapeutic targets. According to an analysis of our RNA sequence data of three paired HCC and non-tumor tissue samples, human maelstrom (MAEL) gene was chosen to study. Our preliminary data suggested that MAEL frequently upregulated in HCC patients, associated with tumor size, adjacent organ invasion, tumor recurrence, and worse overall survival rate. The previous study demonstrated that MAEL promoted HCC cells proliferation and metastasis as well as upregulating several stemness-related genes expression in mRNA level through AKT/GSK3β/Snail signaling pathways. However, the cancer stemness regulating ability and downstream targets of MAEL is still not well studied. Therefore, this project would focus on revealing novel targets of MAEL and further investigate the unique role in regulating cancer stemness. We analyzed MAEL expression and survival data in TCGA LIHC cohort, the results were consistent with our previous findings. We found that overexpress MAEL could not only promote the ability of HCC cell proliferation and mobility in vitro but also increase the proportion of CD133+ cells, self-renew and sorafenib resistant ability. Moreover, knockout MAEL showed reverse results in PLC8024 cell line inhibited these functions. We applied next-generation sequencing (NGS) technology to compare with vector group and MAEL transfected group cells which revealed that MAEL enrolled in the extracellular matrix (ECM) receptor interaction pathways mediated cancer stem cell marker CD44 expression. This finding confirmed by Q-PCR, western blots and flow cytometry. Taken together, these data suggest MAEL could promote HCC cells proliferation, metastasis as well as increasing stem cell features.

Speaker Biography: 
Charon Shi graduated from Capital Medical University in 2015 as the major of Medical Laboratory Tests (MLT). After finished the internship in Beijing Anzhen Hospital, Charon Shi joined in Dept. Clinical Oncology, HKU as research in October 2015. In September 2017, Charon Shi began his postgraduate study in the same laboratory with the supervision of Prof. Dora Kwong and Prof. XY Guan. Our laboratory is focused on discovering novel cancer-related genes and mir-RNAs in gastric cancer (GC), hepatocellular carcinomas (HCC), esophageal carcinomas (ESCC) and nasopharyngeal carcinoma (NPC). Charon Shi current study is supported by the Health and Medical Research Fund.

Comments

Popular posts from this blog

Poster Presentation - Influence of NECC (Nutrition and Exercise Center for Cancer Patients) on survival and body composition in Gastrointestinal Cancer Patients

Abstract BACKGROUND : Gastrointestinal cancer patients are particularly predisposed to develop cancer cachexia. Cachectic patients are characterized by loss of adipose tissue as well as skeletal muscle wasting which has a tremendous impact on quality of life and survival (1, 4). In terms of improvement for this multifactorial syndrome, Klinikum rechts der Isar (MRI) in Munich, Germany has founded NECC, a treatment concept including nutrition intervention and an individual training program. METHODS : In this study we focused on patients with pancreatic (n =15) and upper gastrointestinal cancer (n = 21). Body composition using CT images was analyzed initially, 4 weeks, 3 months and 6 months after initial visit of NECC (Image 1). To underline the outcome, NECC patients were matched to adequate partners who correspond in age, gender, diagnosis with TNM classification and type of surgery. The control group does not receive any further support concerning nutrition and physical exercise

Conference Venue

holiday Inn Rome - Aurelia,Via Aurelia Km, 8400 00165, Rome, Italy About City Rome is the capital city of Italy and Lazio region with 2,872,800 residents in 1,285 km2. It is the fourth most populous city in the European Union by population within city limits. Rome is located in central western Italian peninsulas. Rome has acquired the status of a global city. In 2016, Rome has been ranked as the 14th most visited cities in the world and 3rd most visited cities in Europe. It is a city that is proud of its ancient glorious heritage, a city that once expanded its empire throughout Europe, Africa and Asia. The city of Rome includes tourist places such as Colosseum, Pantheon, Spanish Steps, the Forum, Trevi Fountain, and the catacombs any of the buildings have arches, domes and vaults. Colosseum is one of the famous architecture symbols in Rome which is capable of housing 60,000 spectators and it is the largest amphitheater ever built in the Roman empire and it was used for gladia

Poster Presentation - The Notch ligand DLL1 exerts pro-carcinogenic effects in human breast cancer luminal A MCF-7 cells

Abstract  Background: Breast cancer (BC) is the most common cancer in women and has a high rate of relapse and death. The Notch signaling pathway plays an important role in normal breast development and homeostasis. Dysregulation of Notch receptors and its ligands Jagged1, Jagged2, and DLL4 has been detected in BC and implicated in tumor development, progression, drug resistance, and recurrence. The Notch ligand DLL1 has emerged as a player in BC as its expression is undetectable in normal breast tissues, but moderate to high in BC. In this study, we examined the role of DLL1 in BC luminal A MCF-7 cells. Methodology: DLL1 siRNA and recombinant DLL1 protein were used to evaluate the effects of DLL1 in MCF-7 cells. Gene expression was analyzed by qRT-PCR and immunoblotting. Cell growth and proliferation were assessed by trypan blue exclusion and MTT methods. Microscopy and scratch wound-healing assays were used to evaluate colony formation and cell migration. Findings: In M